ImmuCell Corporation Current Federal, State and Local, Tax Expense (Benefit)
ImmuCell Corporation (ICCC) reported Current Federal, State and Local, Tax Expense (Benefit) of $11.57 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit · last filed 2026-03-30
- ImmuCell Corporation current federal, state and local, tax expense (benefit) for fiscal 2025 was $11.57K, a 15.06% increase from fiscal 2024.
- ImmuCell Corporation current federal, state and local, tax expense (benefit) for fiscal 2024 was $10.06K.
- ImmuCell Corporation current federal, state and local, tax expense (benefit) for fiscal 2020 was $4.50K, a 28.83% increase from fiscal 2019.
- ImmuCell Corporation current federal, state and local, tax expense (benefit) for fiscal 2019 was $3.49K.
| Period end | Current Federal, State and Local, Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $11.57K 10-K · filed 2026-03-30 |
| 2024-12-31 | $10.06K 10-K · filed 2026-03-30 |
| 2020-12-31 | $4.50K 10-K · filed 2021-03-30 |
| 2019-12-31 | $3.49K 10-K · filed 2021-03-30 |
| 2018-12-31 | -$820.00 10-K · filed 2020-03-27 |
| 2017-12-31 | $14.48K 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |